Follitropin delta - Ferring Pharmaceuticals

Drug Profile

Follitropin delta - Ferring Pharmaceuticals

Alternative Names: FE-999049; Recombinant follicle-stimulating hormone - Ferring Pharmaceuticals; Recombinant FSH - Ferring; Rekovelle

Latest Information Update: 14 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ferring Pharmaceuticals
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Registered Female infertility

Most Recent Events

  • 06 Apr 2018 OVO Fertility Clinic in collaboraion with Create Fertility Center, Olive Fertility Centre and Hannam Fertility Centre plans a combination trial of follitropin delta and HP hMG for Female infertility in Canada in May 2018 (NCT03483545)
  • 20 Feb 2018 Ferring Pharmaceuticals initiates enrolment in the PROFILE clinical trial for Female infertility in Austria and Germany (NCT03393780)
  • 01 Dec 2017 Phase-III clinical trials in Female infertility in South Korea, Taiwan (SC) (NCT03296527)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top